FDA Approves First Digital Treatment For Depression In Harlem And Beyond
The #1 source in the world for all things Harlem.
The Food and Drug Administration (FDA) has approved a new smartphone app, Rejoyn, for the treatment of depression. The app was created by Otsuka Pharmaceutical Co. and Click Therapeutics, and it offers users a six-week treatment program for major depressive disorder. This is the first prescription digital therapeutic authorized for depression treatment. “Rejoyn represents a novel and exciting adjunctive treatment…
The post FDA Approves First Digital Treatment For Depression In Harlem And Beyond appeared first on Harlem World Magazine.